152 related articles for article (PubMed ID: 7694008)
1. Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spots.
Bowen DT; Padua RA; Burnett AK; deCastro CM; Kaufman RE
Leukemia; 1993 Nov; 7(11):1883-5. PubMed ID: 7694008
[TBL] [Abstract][Full Text] [Related]
2. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
3. Structural organization of the murine c-kit proto-oncogene.
Gokkel E; Grossman Z; Ramot B; Yarden Y; Rechavi G; Givol D
Oncogene; 1992 Jul; 7(7):1423-9. PubMed ID: 1377813
[TBL] [Abstract][Full Text] [Related]
4. Instability at the W/c-kit locus in mice: analysis of melanocyte cell lines derived from reversion spots.
De Sepulveda P; Peyrieras N; Panthier JJ
Oncogene; 1994 Sep; 9(9):2655-61. PubMed ID: 7520149
[TBL] [Abstract][Full Text] [Related]
5. Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line.
Kanakura Y; Furitsu T; Tsujimura T; Butterfield JH; Ashman LK; Ikeda H; Kitayama H; Kanayama Y; Matsuzawa Y; Kitamura Y
Leukemia; 1994 Apr; 8 Suppl 1():S18-22. PubMed ID: 7512180
[TBL] [Abstract][Full Text] [Related]
6. Analysis of c-kit gene integrity in aplastic anemia.
Paquette RL; Hsu NC; Koeffler HP
Blood Cells Mol Dis; 1996; 22(2):159-68. PubMed ID: 8931956
[TBL] [Abstract][Full Text] [Related]
7. The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis.
Besmer P; Manova K; Duttlinger R; Huang EJ; Packer A; Gyssler C; Bachvarova RF
Dev Suppl; 1993; ():125-37. PubMed ID: 7519481
[TBL] [Abstract][Full Text] [Related]
8. Induction of the murine "W phenotype" in long-term cultures of human cord blood cells by c-kit antisense oligomers.
Migliaccio AR; Migliaccio G; Mancini G; Ratajczak M; Gewirtz AM; Adamson JW
J Cell Physiol; 1993 Oct; 157(1):158-63. PubMed ID: 7691834
[TBL] [Abstract][Full Text] [Related]
9. Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes.
Siitonen T; Savolainen ER; Koistinen P
Leukemia; 1994 Apr; 8(4):631-7. PubMed ID: 7512174
[TBL] [Abstract][Full Text] [Related]
10. Cloning and structural analysis of the human c-kit gene.
Vandenbark GR; deCastro CM; Taylor H; Dew-Knight S; Kaufman RE
Oncogene; 1992 Jul; 7(7):1259-66. PubMed ID: 1377810
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide sequence and structural organization of the human FMS proto-oncogene.
Hampe A; Shamoon BM; Gobet M; Sherr CJ; Galibert F
Oncogene Res; 1989; 4(1):9-17. PubMed ID: 2524025
[TBL] [Abstract][Full Text] [Related]
12. Absence of point mutations in a functionally important part of the extracellular domain of the c-kit proto-oncogene in a series of patients with acute myeloid leukemia (AML).
Arland M; Fiedler W; Samalecos A; Hossfeld DK
Leukemia; 1994 Mar; 8(3):498-501. PubMed ID: 8127154
[TBL] [Abstract][Full Text] [Related]
13. The expression of cytokine receptors by purified hemopoietic stem cells.
Visser JW; Rozemuller H; de Jong MO; Belyavsky A
Stem Cells; 1993 Jul; 11 Suppl 2():49-55. PubMed ID: 7691328
[TBL] [Abstract][Full Text] [Related]
14. The mouse W/c-kit locus.
Bernstein A; Chabot B; Dubreuil P; Reith A; Nocka K; Majumder S; Ray P; Besmer P
Ciba Found Symp; 1990; 148():158-66; discussion 166-72. PubMed ID: 1690623
[TBL] [Abstract][Full Text] [Related]
15. Lack of TP53 and FMS gene mutations in children with myelodysplastic syndrome.
Jekic B; Novakovic I; Lukovic L; Kuzmanovic M; Popovic B; Milasin J; Bunjevacki G; Damnjanovic T; Cvjeticanin S; Bunjevacki V
Cancer Genet Cytogenet; 2006 Apr; 166(2):163-5. PubMed ID: 16631474
[TBL] [Abstract][Full Text] [Related]
16. Genomic organization of the human c-kit gene: evolution of the receptor tyrosine kinase subclass III.
André C; Martin E; Cornu F; Hu WX; Wang XP; Galibert F
Oncogene; 1992 Apr; 7(4):685-91. PubMed ID: 1373482
[TBL] [Abstract][Full Text] [Related]
17. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice.
Duttlinger R; Manova K; Berrozpe G; Chu TY; DeLeon V; Timokhina I; Chaganti RS; Zelenetz AD; Bachvarova RF; Besmer P
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3754-8. PubMed ID: 7537375
[TBL] [Abstract][Full Text] [Related]
18. Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene.
Giebel LB; Strunk KM; Holmes SA; Spritz RA
Oncogene; 1992 Nov; 7(11):2207-17. PubMed ID: 1279499
[TBL] [Abstract][Full Text] [Related]
19. A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12.
Spritz RA; Strunk KM; Lee ST; Lu-Kuo JM; Ward DC; Le Paslier D; Altherr MR; Dorman TE; Moir DT
Genomics; 1994 Jul; 22(2):431-6. PubMed ID: 7528718
[TBL] [Abstract][Full Text] [Related]
20. Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene.
Fleischman RA
J Clin Invest; 1992 Jun; 89(6):1713-7. PubMed ID: 1376329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
